4/A//SEC Filing
THERAVANCE INC 4/A
Accession 0001179110-15-008718
$INVACIK 0001080014operating
Filed
May 28, 8:00 PM ET
Accepted
May 29, 4:25 PM ET
Size
5.3 KB
Accession
0001179110-15-008718
Insider Transaction Report
Form 4/AAmended
THERAVANCE INCTHRX
WALTRIP WILLIAM H
Director
Transactions
- Award
Common Stock
2015-04-24+13,950→ 123,604 total
Footnotes (2)
- [F1]The Reporting Person was granted restricted stock units ("RSUs"). 100% of the RSUs will vest at the sooner of the next annual shareholder meeting or the one-year anniversary of grant, subject to the Reporting Person's continuous service as an Outside Director through the applicable vesting date.
- [F2]The initial Form 4 filed on April 27, 2015 by the Reporting Person inadvertently omitted 6,340 shares of common stock subject to RSUs that the reporting person received as a result of an antidilution adjustment pursuant to the Theravance, Inc. 2012 Equity Incentive Plan as a result of the Issuer's spin-off of Theravance Biopharma, Inc.
Documents
Issuer
THERAVANCE INC
CIK 0001080014
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001080014
Filing Metadata
- Form type
- 4/A
- Filed
- May 28, 8:00 PM ET
- Accepted
- May 29, 4:25 PM ET
- Size
- 5.3 KB